Posted by ABMN Staff on Apr 19th, 2024
CareDx (NASDAQ:CDNA – Get Free Report)‘s stock had its “overweight” rating restated by research analysts at Stephens in a research note issued to investors on Wednesday, Benzinga reports. They presently have...
More of this article »